GlassScriptPhysician profile
Heather Anne Nath
NPI 1588605547
$8,768.44
in general payments reported to CMS, 2019-2025
19 companies · $792 in 2025
The $792 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,585 · 2020: $1,195 · 2021: $970 · 2022: $997 · 2023: $894 · 2024: $336 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,021.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,546.24 | 2019-2024 | Senza |
| Medtronic, INC. | $2,520.06 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Accurian |
| Medtronic USA, INC. | $1,446.41 | 2019-2020 | |
| Boston Scientific Corporation | $552.70 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $487.07 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $477.67 | 2019-2025 | Xtampza, Belbuca |
| Globus Medical, INC. | $203.78 | 2025 | Senza |
| Arbor Pharmaceuticals, INC. | $120.35 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $78.95 | 2019-2021 | |
| Horizon Therapeutics Plc | $64.56 | 2021 | |
| Myoscience INC. | $54.57 | 2019 | |
| Spr Therapeutics, INC | $41.95 | 2025 | Sprint Pns System |
| Ibsa Pharma INC. | $38.47 | 2022-2023 | Tirosint, Licart |
| Pfizer INC. | $37.18 | 2019 | |
| Ethicon US, LLC | $23.65 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $22.51 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $20.27 | 2025 | |
| Almatica Pharma LLC | $18.78 | 2021 | |
| Nalu Medical, INC. | $13.27 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Nath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.